Literature DB >> 12088681

Dendritic cells and immunity to leishmaniasis and toxoplasmosis.

Phillip Scott1, Christopher A Hunter.   

Abstract

There is increased recognition that dendritic cells (DCs) are an important source of the IL-12 required to initiate protective immunity to protozoa, such as Leishmania and Toxoplasma. This article reviews the advances made in the last two years in understanding the pathways that lead to DC activation after infection with these organisms. Interestingly, there appear to be differences in the DC activation pathways utilized by these two intracellular protozoa which also may differ from the pathways utilized by bacteria.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088681     DOI: 10.1016/s0952-7915(02)00353-9

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  22 in total

1.  Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4.

Authors:  Afzal A Siddiqui; Troy Phillips; Hugues Charest; Ron B Podesta; Martha L Quinlin; Justin R Pinkston; Jenny D Lloyd; Michelle Paz; Rachael M Villalovos; Janet Pompa
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  TRAF6-dependent mitogen-activated protein kinase activation differentially regulates the production of interleukin-12 by macrophages in response to Toxoplasma gondii.

Authors:  Nicola J Mason; Jim Fiore; Takashi Kobayashi; Katherine S Masek; Yongwon Choi; Christopher A Hunter
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.

Authors:  Marie Breton; Michel J Tremblay; Marc Ouellette; Barbara Papadopoulou
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii.

Authors:  Marc-Jan Gubbels; Boris Striepen; Nilabh Shastri; Mustafa Turkoz; Ellen A Robey
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  Reduced pathology following infection with transgenic Leishmania major expressing murine CD40 ligand.

Authors:  Ann E Field; Sagie Wagage; Sean M Conrad; David M Mosser
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

6.  Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity.

Authors:  Mario Steigerwald; Heidrun Moll
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction.

Authors:  Michelle A Favila; Nicholas S Geraci; Erliang Zeng; Brent Harker; David Condon; Rachel N Cotton; Asha Jayakumar; Vinita Tripathi; Mary Ann McDowell
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

Review 8.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

9.  Toxoplasma gondii infection of decidual CD1c(+) dendritic cells enhances cytotoxicity of decidual natural killer cells.

Authors:  Xianbing Liu; Mingdong Zhao; Xin Yang; Meiyu Han; Xiaoyan Xu; Yuzhu Jiang; Xuemei Hu
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

10.  Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions.

Authors:  Dong Liu; Chahnaz Kebaier; Nazzy Pakpour; Althea A Capul; Stephen M Beverley; Phillip Scott; Jude E Uzonna
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.